Fibromuscular dysplasia: State of the science and critical unanswered questions: A scientific statement from the american heart association

Circulation

Volumn 129, Issue 9, 2014, Pages 1048-1078

  Olin, Jeffrey W ^a   Gornik, Heather L ^a   Bacharach, J Michael ^a   Biller, Jose ^a   Fine, Lawrence J ^a   Gray, Bruce H ^a   Gray, William A ^a   Gupta, Rishi ^a   Hamburg, Naomi M ^a   Katzen, Barry T ^a   Lookstein, Robert A ^a   Lumsden, Alan B ^a   Newburger, Jane W ^a   Rundek, Tatjana ^a   Sperati, C John ^a   Stanley, James C ^a  

^a NONE

Author keywords

AHA Scientific Statements; aneurysm; dissection; fibromuscular dysplasia; hypertension; renovascular; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ACTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTIN; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PAPAVERINE; THROMBIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ADVENTITIA; AGE DISTRIBUTION; ALDOSTERONE RELEASE; ANEURYSM; ANEURYSM RUPTURE; ANGIOGRAPHY; ANGIOPLASTY; ANTERIOR COMMUNICATING ARTERY; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIHYPERTENSIVE THERAPY; AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA COARCTATION; APHASIA; ARM; ARTERY DILATATION; ARTERY DISEASE; ARTERY DISSECTION; ARTERY LESION; ARTERY OCCLUSION; ARTERY RUPTURE; ARTERY SPASM; ARTICLE; ARTIFICIAL EMBOLISM; ATHEROSCLEROSIS; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BARE METAL STENT; BLOOD CLOTTING TIME; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BLOOD VESSEL WALL; BRACHIAL ARTERY; BRAIN ANGIOGRAPHY; BRAIN ARTERY; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID ARTERY FIBROMUSCULAR DYSPLASIA; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY SURGERY; CASE CONTROL STUDY; CATHETER BASED ANGIOGRAPHY; CELIAC ARTERY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CEREBROVASCULAR FIBROMUSCULAR DYSPLASIA; CHRONIC KIDNEY DISEASE; CLINICAL CLASSIFICATION; CLINICAL DECISION MAKING; CLINICAL INDICATOR; COIL EMBOLIZATION; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; CONNECTIVE TISSUE DISEASE; CONVENTIONAL ANGIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY DISSECTION; CORONARY ARTERY FIBROMUSCULAR DYSPLASIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC CATHETER; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DIZZINESS; DNA POLYMORPHISM; DYSLIPIDEMIA; ECHOGRAPHY; EHLERS DANLOS SYNDROME; ELASTIC FIBER; EMBOLIC PROTECTION FILTER; END STAGE RENAL DISEASE; ENDOVASCULAR REVASCULARIZATION; ESSENTIAL HYPERTENSION; EXTERNAL CAROTID ARTERY; FALSE ANEURYSM; FAMILY HISTORY; FIBRIN DEPOSITION; FIBROMUSCULAR DYSPLASIA; FIRST DEGREE RELATIVE; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; HEADACHE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMIPARESIS; HISTOLOGY; HISTOPATHOLOGY; HISTORY; HORMONE SUBSTITUTION; HUMAN; HYPERPLASIA; HYPERTENSION; IN-STENT RESTENOSIS; INGUINAL REGION; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY; INTRACRANIAL ANEURYSM; INTRAVASCULAR ULTRASOUND; INTRAVENOUS UROGRAPHY; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INFARCTION; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; KIDNEY TUMOR; LIFESTYLE MODIFICATION; LIMB ISCHEMIA; LOEYS DIETZ SYNDROME; LYMPHOCYTE; MAGNETIC RESONANCE ANGIOGRAPHY; MALIGNANT HYPERTENSION; MARFAN SYNDROME; MEDICAL SOCIETY; MESENTERIC ARTERY; MESENTERIC FIBROMUSCULAR DYSPLASIA; MESENTERIC ISCHEMIA; META ANALYSIS (TOPIC); MIDDLE CEREBRAL ARTERY; MORBIDITY; NECK PAIN; NECROTIZING ARTERITIS; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTIVE USE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PENETRANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERFUSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PETROUS BONE; PHENOTYPE; PHYSICAL EXAMINATION; POINT MUTATION; POPULATION; POSTMENOPAUSE; PREGNANCY; PRESSURE GRADIENT; PRESSURE MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REIMPLANTATION; RENAL ARTERY; RENAL ARTERY ANEURYSM; RENAL ARTERY FIBROMUSCULAR DYSPLASIA; RENAL ARTERY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; RESISTANT HYPERTENSION; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; RISK FACTOR; SECOND DEGREE RELATIVE; SECONDARY PREVENTION; SEGMENTAL ARTERIAL MEDIOLYSIS; SENSITIVITY AND SPECIFICITY; SEX RATIO; SMOKING; SMOKING CESSATION; SMOOTH MUSCLE FIBER; SPLEEN ARTERY; SUBARACHNOID HEMORRHAGE; SUDDEN CARDIAC DEATH; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; SURGICAL MORTALITY; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; THROMBOSIS; TINNITUS; TRANSCRANIAL DOPPLER; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; TREATMENT PLANNING; UNINEPHRECTOMY; VASCULAR LESION; VASCULAR STENT; VASCULITIS; VERTEBRAL ARTERY; VERTEBRAL ARTERY FIBROMUSCULAR DYSPLASIA; WILLIAMS BEUREN SYNDROME;

AHA SCIENTIFIC STATEMENTS; ANEURYSM; DISSECTION; FIBROMUSCULAR DYSPLASIA; HYPERTENSION, RENOVASCULAR; STROKE;

ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84895524661     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/01.cir.0000442577.96802.8c     Document Type: Article

References (287)

1. Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011;53:826-836.e1.
2. Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest. 2012;42:338-347.
3. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28.
4. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.
5. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, McBane RD, Kline-Rogers E, White CJ, Gornik HL. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125:3182-3190.
6. Savard S, Steichen O, Azarine A, Azizi M, Jeunemaitre X, Plouin PF. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012;126:3062-3069.
7. Leadbetter W, Burkland L. Hypertension in unilateral renal disease. J Urol. 1938;39:611-626.
8. McCormack L, Hazard J, Poutasse E. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol. 1958;34:582.
9. Palubinskas AJ, Wylie EJ. Roentgen diagnosis of fibromuscular hyperplasia of the renal arteries. Radiology. 1961;76:634-639.
10. Hunt JC. Symposium on hypertension associated with renal artery disease: clinical aspects. Proc Staff Meet Mayo Clin. 1961;36:707-712.
11. Kincaid OW, Davis GD. Renal arteriography in hypertension. Proc Staff Meet Mayo Clin. 1961;36:689-701.
12. McCormack LJ, Poutasse EF, Meaney TF, Noto TJ Jr, Dustan HP. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J. 1966;72:188-198.
13. Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46:161-167.
14. Palubinskas AJ, Ripley HR. Fibromuscular hyperplasia in extrarenal arteries. Radiology. 1964;82:451-455.
15. Connett MC, Lansche JM. Fibromuscular hyperplasia of the internal carotid artery: report of a case. Ann Surg. 1965;162:59-62.
16. Ehrenfeld WK, Stoney RJ, Wylie EJ. Fibromuscular hyperplasia of the internal carotid artery. Arch Surg. 1967;95:284-287.
17. Houser OW, Baker HL Jr, Sandok BA, Holley KE. Cephalic arterial fibromuscular dysplasia. Radiology. 1971;101:605-611.
18. Stanley JC, Fry WJ, Seeger JF, Hoffman GL, Gabrielsen TO. Extracranial internal carotid and vertebral artery fibrodysplasia. Arch Surg. 1974;109:215-222.
19. Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ. Arterial fibrodysplasia. histopathologic character and current etiologic concepts. Arch Surg. 1975;110:561-566.
20. Stanley JC, Fry WJ. Renovascular hypertension secondary to arterial fibrodysplasia in adults: criteria for operation and results of surgical therapy. Arch Surg. 1975;110:922-928.
21. Mettinger KL. Fibromuscular dysplasia and the brain, II: current concept of the disease. Stroke. 1982;13:53-58.
22. Cragg AH, Smith TP, Thompson BH, Maroney TP, Stanson AW, Shaw GT, Hunter DW, Cochran ST. Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology. 1989;172:145-147.
23. Perdu J, Boutouyrie P, Bourgain C, Stern N, Laloux B, Bozec E, Azizi M, Bonaiti-Pellie C, Plouin PF, Laurent S, Gimenez-Roqueplo AP, Jeunemaitre X. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007;21:393-400.
24. Blondin D, Lanzman R, Schellhammer F, Oels M, Grotemeyer D, Baldus SE, Rump LC, Sandmann W, Voiculescu A. Fibromuscular dysplasia in living renal donors: still a challenge to computed tomographic angiography. Eur J Radiol. 2010;75:67-71.
25. Neymark E, LaBerge JM, Hirose R, Melzer JS, Kerlan RK Jr, Wilson MW, Gordon RL. Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery. Radiology. 2000;214:755-760.
26. Andreoni KA, Weeks SM, Gerber DA, Fair JH, Mauro MA, McCoy L, Scott L, Johnson MW. Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography? Transplantation. 2002;73:1112-1116.
27. Hendricks N, Baheti A, Angle JF, Sabri SS, Saad WE, Cutlip D, Matsumoto AH. Prevalence of FMD seen in patients enrolled into the coral trial versus a single institution population of renal donor candidates [abstract]. J Vasc Interv Radiol. 2013;24:S17.
28. Heffelfinger MK, Holley K, Havrison E. Arterial fibromuscular dysplasia studied at autopsy [abstract]. Am J Clin Pathol. 1970;54:274.
29. Touze E, Oppenheim C, Trystram D, Nokam G, Pasquini M, Alamowitch S, Herve D, Garnier P, Mousseaux E, Plouin PF. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke. 2010;5:296-305.
30. Schievink WI, Bjornsson J. Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol. 1996;15:2-6.
31. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001;344:898-906.
32. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009;8:668-678.
33. Sang CN, Whelton PK, Hamper UM, Connolly M, Kadir S, White RI, Sanders R, Liang KY, Bias W. Etiologic factors in renovascular fibromuscular dysplasia: a case-control study. Hypertension. 1989;14:472-479.
34. Savard S, Azarine A, Jeunemaitre X, Azizi M, Plouin PF, Steichen O. Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia. Hypertension. 2013;61:1227-1232.
35. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115:2878-2901.
36. Bigazzi R, Bianchi S, Quilici N, Salvadori R, Baldari G. Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis. 1998;32:E4.
37. Halpern MM, Sanford HS, Viamonte M Jr. Renal-artery abnormalities in three hypertensive sisters: probable familial fibromuscular hyperplasia. JAMA. 1965;194:512-513.
38. Major P, Genest J, Cartier P, Kuchel O. Hereditary fibromuscular dysplasia with renovascular hypertension. Ann Intern Med. 1977;86:583.
39. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980;140:233-236.
40. Gladstien K, Rushton AR, Kidd KK. Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin Genet. 1980;17:115-116.
41. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, Vuagnat A, Jeunemaitre X, Corvol P, Plouin PF. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens. 1997;15(pt 2):1797-1801.
42. Grimbert P, Fiquer-Kempf B, Coudol P, Vuagnat A, Pannier-Moreau I, Corvol P, Plouin PF, Jeunemaitre X. Genetic study of renal artery fibromuscular dysplasia [in French]. Arch Mal Coeur Vaiss. 1998;91:1069-1071.
43. Schievink WI, Debette S. Etiology of cervical artery dissections: the writing is in the wall. Neurology. 2011;76:1452-1453.
44. Bofinger A, Hawley C, Fisher P, Daunt N, Stowasser M, Gordon R. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens. 2001;15:185-190.
45. Schievink WI, Bjornsson J, Parisi JE, Prakash UB. Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency. Mayo Clin Proc. 1994;69:1040-1043.
46. Schievink WI, Puumala MR, Meyer FB, Raffel C, Katzmann JA, Parisi JE. Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. J Neurosurg. 1996;85:503-506.
47. Schievink WI, Meyer FB, Parisi JE, Wijdicks EF. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency. Neurosurgery. 1998;43:229-233.
48. Perdu J, Gimenez-Roqueplo AP, Boutouyrie P, Beaujour S, Laloux B, Nau V, Fiquet-Kempf B, Emmerich J, Tichet J, Plouin PF, Laurent S, Jeunemaitre X. Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens. 2006;24:705-710.
49. Marks SD, Gullett AM, Brennan E, Tullus K, Jaureguiberry G, Klootwijk E, Stanescu HC, Kleta R, Woolf AS. Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations. Pediatr Nephrol. 2011;26:1857-1861.
50. Poloskey SL, Kim E, Sanghani R, Al-Quthami AH, Arscott P, Moran R, Rigelsky CM, Gornik HL. Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc Med. 2012;17:371-378.
51. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association, Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology, Society of Thoracic Surgeons; Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121:e266-e369.
52. Harrison EG Jr, Hunt JC, Bernatz PE. Morphology of fibromuscular dysplasia of the renal artery in renovascular hypertension. Am J Med. 1967;43:97-112.
53. Virmani R, Carter-Monroe N, Taylor AJ. Congenital anomalies and malformations of the vasculature. In: Creager MA, Beckman JA, Loscalzo J, eds. Vascular Medicine: A Companion to Barunwald's Heart Disease. 2nd ed. Philadelphia, PA: Elsevier Saunders 2013.
54. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries: arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med. 1968;104:271-282.
55. Stanley JC, Zelenock GB, Messina LM, Wakefield TW. Pediatric renovascular hypertension: a thirty-year experience of operative treatment. J Vasc Surg. 1995;21:212-226.
56. Stanley JC. Pathological basis of macrovascular renal artery disease. In: Stanley JC, Ernst CB, Fry WJ, eds. Renovascular Hypertension. Philadelphia, PA: W.B. Saunders 1984.
57. Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol. 2008;23:527-536.
58. Alimi Y, Mercier C, Pellissier JF, Piquet P, Tournigand P. Fibromuscular disease of the renal artery: a new histopathologic classification. Ann Vasc Surg. 1992;6:220-224.
59. Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the "gold standard"? J Am Coll Cardiol. 2003;41:1305-1311.
60. Olin JW. Is fibromuscular dysplasia a single disease? Circulation. 2012;126:2925-2927.
61. Foster JH, Oates JA, Rhamy RK, Klatte EC, Burko HC, Michelakis AM. Hypertension and fibromuscular dysplasia of the renal arteries. Surgery. 1969;65:157-181.
62. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain, I: observations on angiographic, clinical and genetic characteristics. Stroke. 1982;13:46-52.
63. O'Dwyer JA, Moscow N, Trevor R, Ehrenfeld WK, Newton TH. Spontaneous dissection of the carotid artery. Radiology. 1980;137:379-385.
64. Ringel SP, Harrison SH, Norenberg MD, Austin JH. Fibromuscular dysplasia: multiple "spontaneous" dissecting aneurysms of the major cervical arteries. Ann Neurol. 1977;1:301-304.
65. Mokri B, Sundt TM Jr, Houser OW, Piepgras DG. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol. 1986;19:126-138.
66. Hart RG, Easton JD. Dissections of cervical and cerebral arteries. Neurol Clin. 1983;1:155-182.
67. Fisher CM, Ojemann RG, Roberson GH. Spontaneous dissection of cervico-cerebral arteries. Can J Neurol Sci. 1978;5:9-19.
68. Schievink WI, Mokri B, O'Fallon WM. Recurrent spontaneous cervical-artery dissection. N Engl J Med. 1994;330:393-397.
69. Bellot J, Gherardi R, Poirier J, Lacour P, Debrun G, Barbizet J. Fibromuscular dysplasia of cervico-cephalic arteries with multiple dissections and a carotid-cavernous fistula: a pathological study. Stroke. 1985;16:255-261.
70. de Bray JM, Marc G, Pautot V, Vielle B, Pasco A, Lhoste P, Dubas F. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis. 2007;23:448-452.
71. Mokri B, Houser OW, Sandok BA, Piepgras DG. Spontaneous dissections of the vertebral arteries. Neurology. 1988;38:880-885.
72. Houser OW, Mokri B, Sundt TM Jr, Baker HL Jr, Reese DF. Spontaneous cervical cephalic arterial dissection and its residuum: angiographic spectrum. AJNR Am J Neuroradiol. 1984;5:27-34.
73. Kim YK, Schulman S. Cervical artery dissection: pathology, epidemiology and management. Thromb Res. 2009;123:810-821.
74. Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology. 1995;45:1517-1522.
75. Hansen HJ, Jorgensen SJ, Engell HC. Acute mesenteric infarction caused by small vessel disease. Acta Chir Scand Suppl. 1976;472:109-111.
76. Price RA, Vawter GF. Arterial fibromuscular dysplasia in infancy and childhood. Arch Pathol. 1972;93:419-426.
77. Aboumrad MH, Fine G, Horn RC Jr. Intimal hyperplasia of small mesenteric arteries: occlusive, with infarction of the intestine. Arch Pathol. 1963;75:196-200.
78. Thevenet A, Latil JL, Albat B. Fibromuscular disease of the external iliac artery. Ann Vasc Surg. 1992;6:199-204.
79. Walter JF, Stanley JC, Mehigan JT, Reuter SR, Guthaner DF. External iliac artery fibrodysplasia. AJR Am J Roentgenol. 1978;131:125-128.
80. Sauer L, Reilly LM, Goldstone J, Ehrenfeld WK, Hutton JE, Stoney RJ. Clinical spectrum of symptomatic external iliac fibromuscular dysplasia. J Vasc Surg. 1990;12:488-495.
81. Yoshimuta T, Akutsu K, Okajima T, Tamori Y, Kubota Y, Takeshita S. Images in cardiovascular medicine: string of beads" appearance of bilateral brachial artery in fibromuscular dysplasia. Circulation. 2008;117:2542-2543.
82. Cheu HW, Mills JL. Digital artery embolization as a result of fibromuscular dysplasia of the brachial artery. J Vasc Surg. 1991;14:225-228.
83. Yoshida T, Ohashi I, Suzuki S, Iwai T. Fibromuscular disease of the brachial artery with digital emboli treated effectively by transluminal angioplasty. Cardiovasc Intervent Radiol. 1994;17:99-101.
84. Lin WW, McGee GS, Patterson BK, Yao JS, Pearce WH. Fibromuscular dysplasia of the brachial artery: a case report and review of the literature. J Vasc Surg. 1992;16:66-70.
85. Shin JS, Han EM, Min BZ, Jung WJ, Jo WM, Lee IS. Fibromuscular dysplasia of bilateral brachial arteries treated with surgery and consecutive thrombolytic therapy. Ann Vasc Surg. 2007;21:93-96.
86. Pate GE, Lowe R, Buller CE. Fibromuscular dysplasia of the coronary and renal arteries? Catheter Cardiovasc Interv. 2005;64:138-145.
87. Saw J, Ricci D, Starovoytov A, Fox R, Buller CE. Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. JACC Cardiovasc Interv. 2013;6:44-52.
88. Lie JT, Berg KK. Isolated fibromuscular dysplasia of the coronary arteries with spontaneous dissection and myocardial infarction. Hum Pathol. 1987;18:654-656.
89. Camuglia A, Manins V, Taylor A, Hengel C. Case report and review: epicardial coronary artery fibromuscular dysplasia. Heart Lung Circ. 2009;18:151-154.
90. Saw J, Poulter R, Fung A, Wood D, Hamburger J, Buller CE. Spontaneous coronary artery dissection in patients with fibromuscular dysplasia: a case series. Circ Cardiovasc Interv. 2012;5:134-137.
91. Cohle SD, Suarez-Mier MP, Aguilera B. Sudden death resulting from lesions of the cardiac conduction system. Am J Forensic Med Pathol. 2002;23:83-89.
92. Zack F, Terpe H, Hammer U, Wegener R. Fibromuscular dysplasia of coronary arteries as a rare cause of death. Int J Legal Med. 1996;108:215-218.
93. Jing HL, Hu BJ. Sudden death caused by stricture of the sinus node artery. Am J Forensic Med Pathol. 1997;18:360-362.
94. Veinot JP, Johnston B, Acharya V, Healey J. The spectrum of intramyocardial small vessel disease associated with sudden death. J Forensic Sci. 2002;47:384-388.
95. Paz Suarez-Mier M, Aguilera B. Histopathology of the conduction system in sudden infant death. Forensic Sci Int. 1998;93:143-154.
96. Dominguez FE, Tate LG, Robinson MJ. Familial fibromuscular dysplasia presenting as sudden death. Am J Cardiovasc Pathol. 1988;2:269-272.
97. Kariks J. Cardiac lesions in sudden infant death syndrome. Forensic Sci Int. 1988;39:211-225.
98. Gornik H, Froehlich J, Gu X, Bacharach J, Gray B, Grise M, Kim E, Kline-Rogers E, Mace P, McBane R, Olin JW. Morbidity, vascular events, and interventional therapy for fibromuscular dysplasia: a report of the Fibromuscular Dysplasia Patient Registry [abstract]. J Am Coll Cardiol. 2011;57:E1453.
99. Devaney K, Kapur SP, Patterson K, Chandra RS. Pediatric renal artery dysplasia: a morphologic study. Pediatr Pathol. 1991;11:609-621.
100. Reid AJ, Bhattacharjee MB, Regalado ES, Milewicz AL, El-Hakam LM, Dauser RC, Milewicz DM. Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric Moyamoya disease. J Neurosurg Pediatr. 2010;6:244-249.
101. Pilz P, Hartjes HJ. Fibromuscular dysplasia and multiple dissecting aneurysms of intracranial arteries: a further cause of Moyamoya syndrome. Stroke. 1976;7:393-398.
102. Yamashita M, Tanaka K, Kishikawa T, Yokota K. Moyamoya disease associated with renovascular hypertension. Hum Pathol. 1984;15:191-193.
103. Jansen JN, Donker AJ, Luth WJ, Smit LM. Moyamoya disease associated with renovascular hypertension. Neuropediatrics. 1990;21:44-47.
104. Choi Y, Kang BC, Kim KJ, Cheong HI, Hwang YS, Wang KC, Kim IO. Renovascular hypertension in children with Moyamoya disease. J Pediatr. 1997;131:258-263.
105. de Vries RR, Nikkels PG, van der Laag J, Broere G, Braun KP. Moyamoya and extracranial vascular involvement: fibromuscular dysplasia? A report of two children. Neuropediatrics. 2003;34:318-321.
106. D'Souza SJ, Tsai WS, Silver MM, Chait P, Benson LN, Silverman E, Hebert D, Balfe JW. Diagnosis and management of stenotic aorto-arteriopathy in childhood. J Pediatr. 1998;132:1016-1022.
107. Suarez WA, Kurczynski TW, Bove EL. An unusual type of combined aortic coarctation due to fibromuscular dysplasia. Cardiol Young. 1999;9:323-326.
108. Grange DK, Balfour IC, Chen SC, Wood EG. Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. Am J Med Genet. 1998;75:469-480.
109. Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2012;20:251-257.
110. Salem JE, Bruguiere E, Iserin L, Guiochon-Mantel A, Plouin PF. Hypertension and aortorenal disease in Alagille syndrome. J Hypertens. 2012;30:1300-1306.
111. Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88:436-440.
112. Edwards BS, Stanson AW, Holley KE, Sheps SG. Isolated renal artery dissection, presentation, evaluation, management, and pathology. Mayo Clin Proc. 1982;57:564-571.
113. Meyers DS, Grim CE, Keitzer WF. Fibromuscular dysplasia of the renal artery with medial dissection: a case simulating polyarteritis nodosa. Am J Med. 1974;56:412-416.
114. Perry MO. Spontaneous renal artery dissection. J Cardiovasc Surg (Torino). 1982;23:54-58.
115. Lacombe M. Isolated spontaneous dissection of the renal artery. J Vasc Surg. 2001;33:385-391.
116. Olin JW, Gu X, Froehlich JB, Bacharach J, Eagle K, Gray B, Grise M, Jaff M, Kim E, Kline-Rogers E, Mace P, Matsumoto R, McBane R, Gornik HL. Peripheral artery dissection in patients with fibromuscular dysplasia: a report from the United States Fibromuscular Dysplasia Patient Registry [abstract]. J Am Coll Cardiol. 2012;59:E2052.
117. Sharma AM, Gornik HL. Standing arterial waves is not fibromuscular dysplasia. Circ Cardiovasc Interv. 2012;5:e9-e11.
118. Lehrer H. The physiology of angiographic arterial waves. Radiology. 1967;89:11-19.
119. Pascual A, Bush HS, Copley JB. Renal fibromuscular dysplasia in elderly persons. Am J Kidney Dis. 2005;45:e63-e66.
120. Sumboonnanonda A, Robinson BL, Gedroyc WM, Saxton HM, Reidy JF, Haycock GB. Middle aortic syndrome: clinical and radiological findings. Arch Dis Child. 1992;67:501-505.
121. Janzen J, Vuong PN, Rothenberger-Janzen K. Takayasu's arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels. 1999;14:277-282.
122. Sen PK, Kinare SG, Engineer SD, Parulkar GB. The middle aortic syndrome. Br Heart J. 1963;25:610-618.
123. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(suppl):S155-S163.
124. Heritz DM, Butany J, Johnston KW, Sniderman KW. Intraabdominal hemorrhage as a result of segmental mediolytic arteritis of an omental artery: case report. J Vasc Surg. 1990;12:561-565.
125. Michael M, Widmer U, Wildermuth S, Barghorn A, Duewell S, Pfammatter T. Segmental arterial mediolysis: CTA findings at presentation and follow-up. AJR Am J Roentgenol. 2006;187:1463-1469.
126. Basso MC, Flores PC, de Azevedo Marques A, de Souza GL, D'Elboux Guimaraes Brescia M, Campos CR, de Cleva R, Saldiva PH, Mauad T. Bilateral extensive cerebral infarction and mesenteric ischemia associated with segmental arterial mediolysis in two young women. Pathol Int. 2005;55:632-638.
127. Inada K, Maeda M, Ikeda T. Segmental arterial mediolysis: unrecognized cases culled from cases of ruptured aneurysm of abdominal visceral arteries reported in the Japanese literature. Pathol Res Pract. 2007;203:771-778.
128. Slavin RE, Saeki K, Bhagavan B, Maas AE. Segmental arterial mediolysis: a precursor to fibromuscular dysplasia? Mod Pathol. 1995;8:287-294.
129. Soulen MC, Cohen DL, Itkin M, Townsend RR, Roberts DA. Segmental arterial mediolysis: angioplasty of bilateral renal artery stenoses with 2-year imaging follow-up. J Vasc Interv Radiol. 2004;15:763-767.
130. Kalva SP, Somarouthu B, Jaff MR, Wicky S. Segmental arterial mediolysis: clinical and imaging features at presentation and during follow-up. J Vasc Interv Radiol. 2011;22:1380-1387.
131. de Sa DJ. Coronary arterial lesions and myocardial necrosis in stillbirths and infants. Arch Dis Child. 1979;54:918-930.
132. Leu HJ. Cerebrovascular accidents resulting from segmental mediolytic arteriopathy of the cerebral arteries in young adults. Cardiovasc Surg. 1994;2:350-353.
133. Yamada M, Ohno M, Itagaki T, Takaba T, Matsuyama T. Coexistence of cystic medial necrosis and segmental arterial mediolysis in a patient with aneurysms of the abdominal aorta and the iliac artery. J Vasc Surg. 2004;39:246-249.
134. Sakata N, Takebayashi S, Shimizu K, Kojima M, Masawa N, Suzuki K, Takatama M. A case of segmental mediolytic arteriopathy involving both intracranial and intraabdominal arteries. Pathol Res Pract. 2002;198:493-497.
135. Filippone EJ, Foy A, Galanis T, Pokuah M, Newman E, Lallas CD, Gonsalves CF, Farber JL. Segmental arterial mediolysis: report of 2 cases and review of the literature. Am J Kidney Dis. 2011;58:981-987.
136. Slavin RE. Segmental arterial mediolysis: course, sequelae, prognosis, and pathologic-radiologic correlation. Cardiovasc Pathol. 2009;18:352-360.
137. Slavin RE, Gonzalez-Vitale JC. Segmental mediolytic arteritis: a clinical pathologic study. Lab Invest. 1976;35:23-29.
138. Luscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62:931-952.
139. Schievink WI, Limburg M. Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type IV. Neurosurgery. 1989;25:482-483.
140. Lassmann G. Vascular dysplasia of arteries in neurocristopathies: a lesson for neurofibromatosis. Neurofibromatosis. 1988;1:281-293.
141. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19:1159-1170.
142. Rountas C, Vlychou M, Vassiou K, Liakopoulos V, Kapsalaki E, Koukoulis G, Fezoulidis IV, Stefanidis I. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital subtraction angiography. Ren Fail. 2007;29:295-302.
143. Eklof H, Ahlstrom H, Magnusson A, Andersson LG, Andren B, Hagg A, Bergqvist D, Nyman R. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47:764-774.
144. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122:833-838.
145. Sabharwal R, Vladica P, Coleman P. Multidetector spiral CT renal angiography in the diagnosis of renal artery fibromuscular dysplasia. Eur J Radiol. 2007;61:520-527.
146. Clemente A, Macchi V, Porzionato A, Stecco C, De Caro R, Morra A. CTA and 2D-3D post-processing: radiological signs of fibromuscular dysplasia of renal artery. Surg Radiol Anat. 2009;31:25-29.
147. Gluecker TM, Mayr M, Schwarz J, Bilecen D, Voegele T, Steiger J, Bachmann A, Bongartz G. Comparison of CT angiography with MR angiography in the preoperative assessment of living kidney donors. Transplantation. 2008;86:1249-1256.
148. Willoteaux S, Faivre-Pierret M, Moranne O, Lions C, Bruzzi J, Finot M, Gaxotte V, Mounier-Vehier C, Beregi JP. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology. 2006;241:922-929.
149. Prasad A, Zafar N, Mahmud E. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements. Catheter Cardiovasc Interv. 2009;74:260-264.
150. Sethi S, Lau J, Erwin P, Gustavson S, Olin JW. The S curve: a novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia [abstract]. J Am Coll Cardiol. 2012;59:E2051.
151. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ. 2011 ASA/AACF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation. 2011;124:489-532.
152. Arnold M, Baumgartner RW, Stapf C, Nedeltchev K, Buffon F, Benninger D, Georgiadis D, Sturzenegger M, Mattle HP, Bousser MG. Ultrasound diagnosis of spontaneous carotid dissection with isolated Horner syndrome. Stroke. 2008;39:82-86.
153. Benninger DH, Georgiadis D, Gandjour J, Baumgartner RW. Accuracy of color duplex ultrasound diagnosis of spontaneous carotid dissection causing ischemia. Stroke. 2006;37:377-381.
154. de Bray JM, Lhoste P, Dubas F, Emile J, Saumet JL. Ultrasonic features of extracranial carotid dissections: 47 cases studied by angiography. J Ultrasound Med. 1994;13:659-664.
155. Lu L, Zhang LJ, Poon CS, Wu SY, Zhou CS, Luo S, Wang M, Lu GM. Digital subtraction CT angiography for detection of intracranial aneurysms: comparison with three-dimensional digital subtraction angiography. Radiology. 2012;262:605-612.
156. Donmez H, Serifov E, Kahriman G, Mavili E, Durak AC, Menku A. Comparison of 16-row multislice CT angiography with conventional angiography for detection and evaluation of intracranial aneurysms. Eur J Radiol. 2011;80:455-461.
157. Anzidei M, Napoli A, Zaccagna F, Di Paolo P, Saba L, Cavallo Marincola B, Zini C, Cartocci G, Di Mare L, Catalano C, Passariello R. Diagnostic accuracy of colour Doppler ultrasonography, CT angiography and blood-pool-enhanced MR angiography in assessing carotid stenosis: a comparative study with DSA in 170 patients. Radiol Med. 2012;117:54-71.
158. Furie DM, Tien RD. Fibromuscular dysplasia of arteries of the head and neck: Imaging findings. AJR Am J Roentgenol. 1994;162:1205-1209.
159. Heiserman JE, Drayer BP, Fram EK, Keller PJ. MR angiography of cervical fibromuscular dysplasia. AJNR Am J Neuroradiol. 1992;13:1454-1457.
160. Bergan JJ, MacDonald JR. Recognition of cerebrovascular fibromuscular hyperplasia. Arch Surg. 1969;98:332-335.
161. Huber P, Fuchs WA. Is there a fibromuscular hyperplasia of cerebral arteries? [in German]. Fortschr Geb Rontgenstr Nuklearmed. 1967;107:119-126.
162. Osborn AG, Anderson RE. Angiographic spectrum of cervical and intracranial fibromuscular dysplasia. Stroke. 1977;8:617-626.
163. Houser OW, Baker HL Jr. Fibromuscular dysplasia and other uncommon diseases of the cervical carotid artery: angiographic aspects. Am J Roentgenol Radium Ther Nucl Med. 1968;104:201-212.
164. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 2003:CD000255.
165. Georgiadis D, Arnold M, von Buedingen HC, Valko P, Sarikaya H, Rousson V, Mattle HP, Bousser MG, Baumgartner RW. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology. 2009;72:1810-1815.
166. Cervical Artery Dissection in Stroke Study Trial Investigators. Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS). Int J Stroke. 2007;2:292-296.
167. Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, Kerry S, Norris J, Markus HS; CADISS Investigators. Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology. 2012;79:686-689.
168. Ramamoorthy SL, Vasquez JC, Taft PM, McGinn RF, Hye RJ. Nonoperative management of acute spontaneous renal artery dissection. Ann Vasc Surg. 2002;16:157-162.
169. Stawicki SP, Rosenfeld JC, Weger N, Fields EL, Balshi JD. Spontaneous renal artery dissection: three cases and clinical algorithms. J Hum Hypertens. 2006;20:710-718.
170. Dustan HP, Page IH, Poutasse EF, Wilson L. An evaluation of treatment of hypertension associated with occlusive renal arterial disease. Circulation. 1963;27:1018-1027.
171. Shapiro AP, Perez-Stable E, Scheib ET, Bron K, Moutsos SE, Berg G, Misage JR. Renal artery stenosis and hypertension: observations on current status of therapy from a study of 115 patients. Am J Med. 1969;47:175-193.
172. Kjellbo H, Lund N, Bergentz SE, Hood B. Renal artery stenosis and hypertension, II: mortality in operated patients compared with the mortality in individually matched medically treated patients with cryptogenetic hypertension. Scand J Urol Nephrol. 1970;4:43-47.
173. Fyhrquist F, Gronhagen-Riska C, Tikkanen I, Junggren IL. Long-term monotherapy with lisinopril in renovascular hypertension. J Cardiovasc Pharmacol. 1987;9(suppl 3):S61-S65.
174. Hollenberg NK. The treatment of renovascular hypertension: surgery, angioplasty, and medical therapy with converting-enzyme inhibitors. Am J Kidney Dis. 1987;10(suppl 1):52-60.
175. Hagg A, Lorelius LE, Morlin C, Aberg H. Percutaneous transluminal renal artery dilatation for fibromuscular dysplasia with special reference to the acute effects on the renin-angiotensin-aldosterone-system and blood pressure. Acta Med Scand Suppl. 1985;693:93-96.
176. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
177. Tanemoto M, Takase K, Yamada T, Satoh A, Abe T, Ito S. Dilation of renal artery stenosis after administration of losartan. Hypertens Res. 2007;30:999-1002.
178. Mazza A, Cuppini S, Zamboni S, Schiavon L, Zattoni L, Viale A, Corbetti F, Ravenni R, Sacco A, Casiglia E. Does treatment with olmesartan improve arterial stenoses due to fibromuscular dysplasia? Hypertens Res. 2009;32:927-929.
179. Lindner V. Vascular repair processes mediated by transforming growth factor-beta. Z Kardiol. 2001;90(suppl 3):17-22.
180. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008;358:2787-2795.
181. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
182. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
183. Bofinger A, Hawley C, Fisher P, Daunt N, Stowasser M, Gordon R. Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. J Hum Hypertens. 1999;13:517-520.
184. Nicholson JP, Teichman SL, Alderman MH, Sos TA, Pickering TG, Laragh JH. Cigarette smoking and renovascular hypertension. Lancet. 1983;2:765-766.
185. Petronio AS, Amoroso G, Limbruno U, Papini B, De Carlo M, Micheli A, Ciabatti N, Mariani M. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am Heart J. 2005;149:520-526.
186. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48:865-871.
187. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, Havas S, Labarthe DR, Limacher MC, Lloyd-Jones DM, Mora S, Pearson TA, Radford MJ, Smetana GW, Spertus JA, Swegler EW. AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease). Circulation. 2009;120:1296-1336.
188. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA, World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458-2473.
189. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, McBride P, Eckel RH, Schwartz JS, Goldberg AC, Shero ST, Gordon D, Smith SC Jr, Levy D, Watson K, Wilson PW. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published online ahead of print November 12, 2013]. Circulation. doi: 10.1161/01.cir.0000437738.63853.7a.
190. Goncharenko V, Gerlock AJ Jr, Shaff MI, Hollifield JW. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology. 1981;139:45-51.
191. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.
192. Meaney TF, Dustan HP, McCormack LJ. Natural history of renal arterial disease. Radiology. 1968;91:881-887.
193. Sheps SG, Kincaid OW, Hunt JC. Serial renal function and angiographic observations in idiopathic fibrous and fibromuscular stenoses of the renal arteries. Am J Cardiol. 1972;30:55-60.
194. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg. 2002;23:146-152.
195. Baumgartner I, Triller J, Mahler F. Patency of percutaneous transluminal renal angioplasty: a prospective sonographic study. Kidney Int. 1997;51:798-803.
196. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56:525-532.
197. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). Circulation. 2006;113:e463-654.
198. Sheikh KH, Davidson CJ, Newman GE, Kisslo KB, Schwab SJ. Intravascular ultrasound assessment of the renal artery. Ann Intern Med. 1991;115:22-25.
199. Pratap T, Sloand JA, Narins CR. Potential pitfalls of renal angiography: a case of atypical fibromuscular dysplasia. Angiology. 2008;59:753-756.
200. Kim HJ, Do YS, Shin SW, Park KB, Cho SK, Choe YH, Choo SW, Choo IW, Kim DK. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results. Korean J Radiol. 2008;9:38-44.
201. Barrier P, Julien A, Guillaume C, Philippe O, Herve R, Francis J. Technical and clinical results after percutaneous angioplasty in nonmedial fibromuscular dysplasia: outcome after endovascular management of unifocal renal artery stenoses in 30 patients. Cardiovasc Intervent Radiol. 2010;33:270-277.
202. Oguzkurt L, Tercan F, Gulcan O, Turkoz R. Rupture of the renal artery after cutting balloon angioplasty in a young woman with fibromuscular dysplasia. Cardiovasc Intervent Radiol. 2005;28:360-363.
203. Imamura H, Isobe M, Takenaka H, Kinoshita O, Sekiguchi M, Ohta M. Successful stenting of bilateral renal artery stenosis due to fibromuscular dysplasia assessed by use of pressure guidewire technique: a case report. Angiology. 1998;49:69-74.
204. Cianci R, Stivali G, Gigante A, Di Donato D, Polidori L, Clemenzia G, Borghesi F, Renzulli R, Martina P, Gasperini ML, Barbano B. Primary stenting for renal fibromuscular-dysplastic stenosis: a case report. Eur Rev Med Pharmacol Sci. 2009;13:317-319.
205. Raju MG, Bajzer CT, Clair DG, Kim E, Gornik HL. Renal artery stent fracture in patients with fibromuscular dysplasia: a cautionary tale. Circ Cardiovasc Interv. 2013;6:e30-e31.
206. Sciacca L, Ciocca RG, Eslami MH, Messina LM. Endovascular treatment of renal artery aneurysm secondary to fibromuscular dysplasia: a case report. Ann Vasc Surg. 2009;23:536.e539-536.e12.
207. Bisschops RH, Popma JJ, Meyerovitz MF. Treatment of fibromuscular dysplasia and renal artery aneurysm with use of a stent-graft. J Vasc Interv Radiol. 2001;12:757-760.
208. Bui BT, Oliva VL, Leclerc G, Courteau M, Harel C, Plante R, Giroux D, Carignan L. Renal artery aneurysm: treatment with percutaneous placement of a stent-graft. Radiology. 1995;195:181-182.
209. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, Vaughan ED Jr, Laragh JH. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983;309:274-279.
210. Baert AL, Wilms G, Amery A, Vermylen J, Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol. 1990;13:22-28.
211. Tegtmeyer CJ, Selby JB, Hartwell GD, Ayers C, Tegtmeyer V. Results and complications of angioplasty in fibromuscular disease. Circulation. 1991;83(suppl):I155-I161.
212. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, Sheedy PF 2nd, Welch TJ, Schirger A. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995;70:1041-1052.
213. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995;48:1936-1945.
214. Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis. 1996;28:334-338.
215. Klow NE, Paulsen D, Vatne K, Rokstad B, Lien B, Fauchald P. Percutaneous transluminal renal artery angioplasty using the coaxial technique: ten years of experience from 591 procedures in 419 patients. Acta Radiol. 1998;39:594-603.
216. Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, Davies MG. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2003;17:650-655.
217. de Fraissinette B, Garcier JM, Dieu V, Mofid R, Ravel A, Boire JY, Boyer L. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol. 2003;26:46-51.
218. Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF. Short-and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg. 2012;55:421-427.
219. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ. 1990;300:569-572.
220. Matsumoto AH, Spinosa DJ, Angle JF, Hagspiel KD, Leung DA. Evaluation and endovascular therapy for renal artery stenosis. Abrams' Angiography: Interventional Radiology. Philadelphia, PA: Lippincott Williams & Wilkins; 2006 362-397.
221. Smit JV, Wierema TK, Kroon AA, de Leeuw PW. Blood pressure and renal function before and after percutaneous transluminal renal angioplasty in fibromuscular dysplasia: a cohort study. J Hypertens. 2013;31:1183-1188.
222. Archibald GR, Beckmann CF, Libertino JA. Focal renal artery stenosis caused by fibromuscular dysplasia: treatment by percutaneous transluminal angioplasty. AJR Am J Roentgenol. 1988;151:593-596.
223. Hughes RJ, Scoble JE, Reidy JF. Renal angioplasty in non-atheromatous renal artery stenosis: technical results and clinical outcome in 43 patients. Cardiovasc Intervent Radiol. 2004;27:435-440.
224. Dubel GJ, Murphy TP. The role of percutaneous revascularization for renal artery stenosis. Vasc Med. 2008;13:141-156.
225. Anderson CA, Hansen KJ, Benjamin ME, Keith DR, Craven TE, Dean RH. Renal artery fibromuscular dysplasia: results of current surgical therapy. J Vasc Surg. 1995;22:207-215.
226. Hunt JC, Strong CG. Renovascular hypertension: mechanisms, natural history and treatment. Am J Cardiol. 1973;32:562-574.
227. Martinez A, Novick AC, Cunningham R, Goormastic M. Improved results of vascular reconstruction in pediatric and young adult patients with renovascular hypertension. J Urol. 1990;144:717-720.
228. Stanley JC. The evolution of surgery for renovascular occlusive disease. Cardiovasc Surg. 1994;2:195-202.
229. van Bockel JH, van Schilfgaarde R, Felthuis W, van Brummelen P, Hermans J, Terpstra JL. Long-term results of in situ and extracorporeal surgery for renovascular hypertension caused by fibrodysplasia. J Vasc Surg. 1987;6:355-364.
230. Bergentz SE, Ericsson BF, Husberg B. Technique and complications in the surgical treatment of renovascular hypertension. Acta Chir Scand. 1979;145:143-148.
231. Lawrie GM, Morris GC Jr, Soussou ID, Starr DS, Silvers A, Glaeser DH, DeBakey ME. Late results of reconstructive surgery for renovascular disease. Ann Surg. 1980;191:528-533.
232. Novick AC, Banowsky LH, Stewart BH, Straffon RA. Splenorenal bypass in the treatment of renal artery stenosis. Trans Am Assoc Genitourin Surg. 1977;69:139-145.
233. Novick AC, Straffon RA, Stewart BH, Gifford RW, Vidt D. Diminished operative morbidity and mortality in renal revascularization. JAMA. 1981;246:749-753.
234. Stanley JC. David M. Hume memorial lecture: surgical treatment of renovascular hypertension. Am J Surg. 1997;174:102-110.
235. Straffon R, Siegel DF. Saphenous vein bypass graft in the treatment of renovascular hypertension. Urol Clin North Am. 1975;2:337-350.
236. Stoney RJ, De Luccia N, Ehrenfeld WK, Wylie EJ. Aortorenal arterial autografts: long-term assessment. Arch Surg. 1981;116:1416-1422.
237. Foster JH, Dean RH, Pinkerton JA, Rhamy RK. Ten years experience with the surgical management of renovascular hypertension. Ann Surg. 1973;177:755-766.
238. Stanley JC, Whitehouse WM, Graham LM, Cronenwett JL, Zelenock GB, Lindenauer SM. Operative therapy of renovascular hypertension. Br J Surg. 1982;69:S63-S66.
239. Stanley JC, Henke P. Renal artery bypass. In: Lumley JS, Hoballab JJ, eds. Vascular Surgery:. Springer Surgery Atlas Series. Berlin, Germany: Springer-Verlag 2009.
240. Stanley JC. Renovascular hypertension: surgical treatment. Urol Radiol. 1981-1982;3:205-208.
241. Stanley JC, Ernst CB, Fry WJ. Fate of 100 aortorenal vein grafts: characteristics of late graft expansion, aneurysmal dilatation, and stenosis. Surgery. 1973;74:931-944.
242. Stanley JC, Criado E, Upchurch GR Jr, Brophy PD, Cho KJ, Rectenwald JE; Michigan Pediatric Renovascular Group, Kershaw DB, Williams DM, Berguer R, Henke PK, Wakefield TW. Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg. 2006;44:1219-1228.
243. Chiche L, Kieffer E, Sabatier J, Colau A, Koskas F, Bahnini A. Renal autotransplantation for vascular disease: late outcome according to etiology. J Vasc Surg. 2003;37:353-361.
244. Crutchley TA, Pearce JD, Craven TE, Edwards MS, Dean RH, Hansen KJ. Branch renal artery repair with cold perfusion protection. J Vasc Surg. 2007;46:405-412.
245. Chibaro EA, Libertino JA, Novick AC. Use of the hepatic circulation for renal revascularization. Ann Surg. 1984;199:406-411.
246. Khauli RB, Novick AC, Ziegelbaum M. Splenorenal bypass in the treatment of renal artery stenosis: experience with sixty-nine cases. J Vasc Surg. 1985;2:547-551.
247. Novick AC, Stewart R, Hodge EE, Goldfarb D. Use of the thoracic aorta for renal arterial reconstruction. J Vasc Surg. 1994;19:605-609.
248. Moncure AC, Brewster DC, Darling RC, Atnip RG, Newton WD, Abbott WM. Use of the splenic and hepatic arteries for renal revascularization. J Vasc Surg. 1986;3:196-203.
249. Buda JA, Baer L, Parra-Carrillo JZ, Kashef MM, McAllister FF, Voorhees AB, Pirani CL. Predictability of surgical response in renovascular hypertension. Arch Surg. 1976;111:1243-1248.
250. Stoney RJ, Silane M, Salvatierra O Jr. Ex vivo renal artery reconstruction. Arch Surg. 1978;113:1272-1278.
251. Jakubowski HD, Eigler FW, Montag H. Results of surgery in fibrodysplastic renal artery stenosis. World J Surg. 1981;5:859-861.
252. Novick AC, Ziegelbaum M, Vidt DG, Gifford RW Jr, Pohl MA, Goormastic M. Trends in surgical revascularization for renal artery disease: ten years' experience. JAMA. 1987;257:498-501.
253. Hagg A, Aberg H, Eriksson I, Lorelius LE, Morlin C. Fibromuscular dysplasia of the renal artery: management and outcome. Acta Chir Scand. 1987;153:15-20.
254. Hansen KJ, Starr SM, Sands RE, Burkart JM, Plonk GW Jr, Dean RH. Contemporary surgical management of renovascular disease. J Vasc Surg. 1992;16:319-330.
255. Murray SP, Kent C, Salvatierra O, Stoney RJ. Complex branch renovascular disease: management options and late results. J Vasc Surg. 1994;20:338-345.
256. Wong JM, Hansen KJ, Oskin TC, Craven TE, Plonk GW Jr, Ligush J Jr, Dean RH. Surgery after failed percutaneous renal artery angioplasty. J Vasc Surg. 1999;30:468-482.
257. Reiher L, Pfeiffer T, Sandmann W. Long-term results after surgical reconstruction for renal artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg. 2000;20:556-559.
258. Marekovic Z, Mokos I, Krhen I, Goreta NR, Roncevic T. Long-term outcome after surgical kidney revascularization for fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Urol. 2004;171:1043-1045.
259. Carmo M, Bower TC, Mozes G, Nachreiner RD, Textor SC, Hoskin TL, Kalra M, Noel AA, Panneton JM, Sullivan TM, Gloviczki P. Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg. 2005;19:208-217.
260. Lacombe M, Ricco JB. Surgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty. J Vasc Surg. 2006;44:537-544.
261. Lindblad B, Gottsa A. Renal disease fibrodysplasia. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery, 7th Edition. Philadelphia, PA: Elsevier; 2010.
262. Stoney RJ, Cooke PA, String ST. Surgical treatment of renovascular hypertension in children. J Pediatr Surg. 1975;10:631-639.
263. Lawson JD, Boerth R, Foster JH, Dean RH. Diagnosis and management of renovascular hypertension in children. Arch Surg. 1977;112:1307-1316.
264. Novick AC, Straffon RA, Stewart BH, Benjamin S. Surgical treatment of renovascular hypertension in the pediatric patient. J Urol. 1978;119:794-799.
265. O'Neill JA Jr. Long-term outcome with surgical treatment of renovascular hypertension. J Pediatr Surg. 1998;33:106-111.
266. Lacombe M. Role of surgery in the treatment of renovascular hypertension in the child [in French]. Bull Acad Natl Med. 2003;187:1081-1093.
267. Chalmers RT, Dhadwal A, Deal JE, Sever PS, Wolfe JH. The surgical management of renovascular hypertension in children and young adults. Eur J Vasc Endovasc Surg. 2000;19:400-405.
268. Piercy KT, Hundley JC, Stafford JM, Craven TE, Nagaraj SK, Dean RH, Hansen KJ. Renovascular disease in children and adolescents. J Vasc Surg. 2005;41:973-982.
269. Huang Y, Duncan AA, McKusick MA, Milliner DS, Bower TC, Kalra M, Gloviczki P, Hoskin TL. Renal artery intervention in pediatric and adolescent patients: a 20-year experience. Perspect Vasc Surg Endovasc Ther. 2008;41:490-499.
270. Modrall JG, Rosero EB, Smith ST, Arko FR 3rd, Valentine RJ, Clagett GP, Timaran CH. Operative mortality for renal artery bypass in the United States: results from the National Inpatient Sample. J Vasc Surg. 2008;48:317-322.
271. Oertle M, Do DD, Baumgartner I, Triller J, Mahler F. Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty (PTRA). Vasa. 1998;27:154-157.
272. Edwards JM, Zaccardi MJ, Strandness DE Jr. A preliminary study of the role of duplex scanning in defining the adequacy of treatment of patients with renal artery fibromuscular dysplasia. J Vasc Surg. 1992;15:604-609.
273. Edgell RC, Abou-Chebl A, Yadav JS. Endovascular management of spontaneous carotid artery dissection. J Vasc Surg. 2005;42:854-860.
274. Effeney DJ, Ehrenfeld WK, Stoney RJ, Wylie EJ. Why operate on carotid fibromuscular dysplasia? Arch Surg. 1980;115:1261-1265.
275. Wesen CA, Elliott BM. Fibromuscular dysplasia of the carotid arteries. Am J Surg. 1986;151:448-451.
276. Finsterer J, Strassegger J, Haymerle A, Hagmuller G. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry. 2000;69:683-686.
277. Maher CO, Meyer FB. Surgical treatment of nonatherosclerotic lesions of the extracranial carotid artery. Neurosurg Clin N Am. 2000;11:309-322.
278. Olin JW. Re: Carotid artery fibromuscular dysplasia [comment]. Am J Surg. 2007;194:419.
279. Moreau P, Albat B, Thevenet A. Fibromuscular dysplasia of the internal carotid artery: long-term surgical results. J Cardiovasc Surg (Torino). 1993;34:465-472.
280. Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103-110.
281. Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336:28-40.
282. Locksley HB. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations: based on 6368 cases in the cooperative study. J Neurosurg. 1966;25:219-239.
283. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
284. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
285. UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366:2474-2482.
286. van der Kolk NM, Algra A, Rinkel GJ. Risk of aneurysm rupture at intracranial arterial bifurcations. Cerebrovasc Dis. 2010;30:29-35.
287. Komotar RJ, Mocco J, Solomon RA. Guidelines for the surgical treatment of unruptured intracranial aneurysms: the first annual J. Lawrence Pool Memorial Research Symposium: controversies in the management of cerebral aneurysms. Neurosurgery. 2008;62:183-193.